Difficulty in walking is seen in many people with peripheral neuropathies, but walking ability is not comprehensively measured by commonly used outcome measures. The clinimetric properties of the 12-Item Multiple Sclerosis Walking Scale (MSWS-12, renamed the Walk-12) were investigated in 65 patients with peripheral neuropathies. Owing to its excellent internal consistency and reliability, and strong correlation with measures of physical and social function (r>0.8), the Walk-12 is recommended for measuring walking ability in peripheral neuropathies.
- CIAP, chronic idiopathic axonal neuropathy
- CIDP, chronic inflammatory demyelinating polyradiculoneuropathy
- CMT, Charcot–Marie–Tooth disease
- GBS, Guillain–Barré syndrome
- MMN, multifocal motor neuropathy
- MRC Sum Score, Medical Research Council Sum Score
- ODSS, Overall Disability Sum Score
- ONLS, Overall Neuropathy Limitations Scale
- PDN, paraproteinaemic demyelinating neuropathy
- SF-36 Questionnaire, 36-Item Short-Form Questionnaire
- Walk-12, 12-Item Walking Scale
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.